Nemysis Ltd Announces Grant of First Chinese Patent for IHAT
Nemysis Ltd Announces Grant of First Chinese Patent for IHAT, the Novel Iron Nanoparticulate Supplement for Iron Deficiency (ID) and Iron Deficiency With Anemia (IDA).
News provided by
Share this article
Share this article
DUBLIN, May 12, 2021 /PRNewswire/ Nemysis Ltd today announced the issuance of China Patent Number 201680058940.3 titled Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses . This is the
first patent issued to Nemysis in China in the field of oral iron supplementation in conditions of ID and IDA. The patent claims describe methods for producing IHAT (Iron Hydroxide Adipate Tartrate), where Generally Recognised As Safe (GRAS) organic acids, and particularly Tartaric and Adipic acids, are used to modify the ferrihydrite nanocore of ferritin - the dietary and iron storage form of iron - increasing iron availability upon increased iron d
Share this article
Share this article
DUBLIN, April 29, 2021 /PRNewswire/ Nemysis Ltd announced today the appointment of Dr. Margit Holzer to its Scientific Advisory Board (SAB).
Dr. Margit Holzer, Scientific Director at Ulysse-Consult Sarl, is a passionate biochemical engineer with internationally recognized expertise in development, industrialization and implementation of biotechnological production processes, in the field of pharma and food applications.
Nemysis Ltd
Holzer holds a master s and a PhD in biotechnology from the University of Natural Resources and Applied Life Sciences in Vienna (Austria) and has worked internationally for Boehringer-Ingelheim and Novasep, holding various executive positions in R&D, production, quality, technology and business worldwide.
Nemysis Ltd Announces Appointment of Dr Margit Holzer to Its Scientific Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert, Linda Cavaletti
Nemysis Ltd today announces the appointment of internationally recognized drug discovery and development expert Linda Cavaletti to its Scientific Advisory Board (SAB)
News provided by
Share this article
Share this article
DUBLIN, April 23, 2021 /PRNewswire/ Nemysis Ltd today announces the appointment of internationally recognized drug discovery and development expert Linda Cavaletti to its Scientific Advisory Board (SAB).
Since its inception, Nemysis has initiated and developed high-value innovative R&D programs, including one targeting Celiac Disease and Non-Celiac Gluten intolerance, with the aim of bringing novel treatments to patients suffering from these conditions.
Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert, Linda Cavaletti prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.